RadNet, Inc. (RDNT) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $310.06M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -14.69× | Operating cash flow / net income. Period ending 2026-06-30. $310.06M ÷ $-21.11M ≈ -14.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 310.06M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 2.27B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -21.11M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $310.06M | (m) | (m) | $2.27B | (m) | $-21.11M | (m) | (m) | (m) | -14.69× |
| 2026-03-31 | (m) | (m) | $336.31M | (m) | (m) | $2.14B | (m) | $-14.19M | (m) | (m) | (m) | -23.70× |
| 2025-12-31 | (m) | (m) | $298.82M | (m) | (m) | $2.04B | (m) | $-18.65M | (m) | (m) | (m) | -16.02× |
| 2025-09-30 | (m) | (m) | $257.19M | (m) | (m) | $1.97B | (m) | $-12.71M | (m) | (m) | (m) | -20.23× |
| 2025-06-30 | (m) | (m) | $261.76M | (m) | (m) | $1.91B | (m) | $-14.92M | (m) | (m) | (m) | -17.55× |
| 2025-03-31 | (m) | (m) | $257.42M | (m) | (m) | $1.87B | (m) | $-32.35M | (m) | (m) | (m) | -7.96× |
| 2024-12-31 | (m) | (m) | $233.02M | (m) | (m) | $1.83B | (m) | $2.79M | (m) | (m) | (m) | 83.43× |
| 2024-09-30 | (m) | (m) | $279.41M | (m) | (m) | $1.77B | (m) | $-4.41M | (m) | (m) | (m) | -63.33× |
| 2024-06-30 | (m) | (m) | $253.26M | (m) | (m) | $1.71B | (m) | $9.92M | (m) | (m) | (m) | 25.53× |
| 2024-03-31 | (m) | (m) | $205.33M | (m) | (m) | $1.66B | (m) | $21.27M | (m) | (m) | (m) | 9.65× |
| 2023-12-31 | (m) | (m) | $220.86M | (m) | (m) | $1.62B | (m) | $3.04M | (m) | (m) | (m) | 72.56× |
| 2023-09-30 | (m) | (m) | $185.59M | (m) | (m) | $1.58B | (m) | $3.97M | (m) | (m) | (m) | 46.76× |
| 2023-06-30 | (m) | (m) | $181.36M | (m) | (m) | $1.53B | (m) | $-12.90M | (m) | (m) | (m) | -14.05× |
| 2023-03-31 | (m) | (m) | $178.13M | (m) | (m) | $1.48B | (m) | $-13.37M | (m) | (m) | (m) | -13.33× |
| 2022-12-31 | (m) | (m) | $146.42M | (m) | (m) | $1.43B | (m) | $10.65M | (m) | (m) | (m) | 13.75× |
| 2022-09-30 | (m) | (m) | $141.97M | (m) | (m) | $1.38B | (m) | $7.76M | (m) | (m) | (m) | 18.29× |
| 2022-06-30 | (m) | (m) | $156.53M | (m) | (m) | $1.36B | (m) | $23.31M | (m) | (m) | (m) | 6.71× |
| 2022-03-31 | (m) | (m) | $122.31M | (m) | (m) | $1.34B | (m) | $18.28M | (m) | (m) | (m) | 6.69× |
| 2021-12-31 | (m) | (m) | $149.49M | (m) | (m) | $1.32B | (m) | $24.73M | (m) | (m) | (m) | 6.05× |
| 2021-09-30 | (m) | (m) | $163.71M | (m) | (m) | $1.29B | (m) | $34.51M | (m) | (m) | (m) | 4.74× |
| 2021-06-30 | (m) | (m) | $161.00M | (m) | (m) | $1.25B | (m) | $24.44M | (m) | (m) | (m) | 6.59× |
| 2021-03-31 | (m) | (m) | $220.93M | (m) | (m) | $1.11B | (m) | $10.98M | (m) | (m) | (m) | 20.13× |
| 2020-12-31 | (m) | (m) | $233.76M | (m) | (m) | $1.07B | (m) | $-14.84M | (m) | (m) | (m) | -15.75× |
| 2020-09-30 | (m) | (m) | $192.06M | (m) | (m) | $938.80M | (m) | $-10.40M | (m) | (m) | (m) | -18.47× |
| 2020-06-30 | (m) | (m) | $191.25M | (m) | (m) | $939.72M | (m) | $-13.36M | (m) | (m) | (m) | -14.31× |
| 2020-03-31 | (m) | (m) | $118.33M | (m) | (m) | $1.04B | (m) | $2.13M | (m) | (m) | (m) | 55.53× |
| 2019-12-31 | $30.17M | (m) | $104.32M | $74.15M | (m) | $1.03B | (m) | $14.76M | (m) | (m) | 2.93% | 7.07× |
| 2019-09-30 | $33.65M | (m) | $111.50M | $77.85M | (m) | $1.11B | (m) | $33.50M | (m) | (m) | 3.03% | 3.33× |
| 2019-06-30 | $36.95M | (m) | $114.34M | $77.39M | (m) | $1.06B | (m) | $35.34M | (m) | (m) | 3.49% | 3.24× |
| 2019-03-31 | $38.17M | (m) | $119.34M | $81.17M | (m) | $1.02B | (m) | $35.85M | (m) | (m) | 3.76% | 3.33× |
| 2018-12-31 | $44.57M | (m) | $116.75M | $72.18M | (m) | $975.15M | (m) | $32.24M | (m) | (m) | 4.57% | 3.62× |
| 2018-09-30 | $83.38M | (m) | $154.50M | $71.12M | (m) | (m) | (m) | $-4.17M | (m) | (m) | (m) | -37.09× |
| 2018-06-30 | $75.19M | (m) | $139.01M | $63.82M | (m) | (m) | (m) | $-5.98M | (m) | (m) | (m) | -23.25× |
| 2018-03-31 | $80.73M | (m) | $135.64M | $54.91M | (m) | (m) | (m) | $-6.08M | (m) | (m) | (m) | -22.33× |
| 2017-12-31 | $80.89M | (m) | $142.22M | $61.34M | (m) | $922.19M | (m) | $53.00K | (m) | (m) | 8.77% | 2683.49× |
| 2017-09-30 | $25.25M | (m) | $29.38M | $4.13M | (m) | $911.57M | (m) | $16.97M | (m) | (m) | 2.77% | 1.73× |
| 2017-06-30 | $1.45M | (m) | $7.26M | $5.82M | (m) | $908.61M | (m) | $15.39M | (m) | (m) | 0.16% | 0.47× |
| 2017-03-31 | $7.16M | (m) | $18.46M | $11.31M | (m) | $897.16M | (m) | $13.70M | (m) | (m) | 0.80% | 1.35× |
| 2016-12-31 | $32.39M | (m) | $91.64M | $59.25M | (m) | $884.53M | (m) | $7.23M | (m) | (m) | 3.66% | 12.68× |
| 2016-09-30 | $15.54M | (m) | $32.88M | $17.33M | (m) | $875.30M | (m) | $9.90M | (m) | (m) | 1.78% | 3.32× |
| 2016-06-30 | $29.10M | (m) | $41.68M | $12.58M | (m) | $859.02M | (m) | $16.24M | (m) | (m) | 3.39% | 2.57× |
| 2016-03-31 | $15.07M | (m) | $21.70M | $6.63M | (m) | $844.75M | (m) | $16.01M | (m) | (m) | 1.78% | 1.36× |
| 2015-12-31 | $24.07M | (m) | $67.04M | $42.96M | (m) | $809.63M | (m) | $7.71M | (m) | (m) | 2.97% | 8.70× |
| 2015-09-30 | $14.23M | (m) | $19.74M | $5.51M | (m) | (m) | (m) | $20.32M | (m) | (m) | (m) | 0.97× |
| 2015-06-30 | $16.47M | (m) | $21.99M | $5.52M | (m) | $755.17M | (m) | $16.78M | (m) | (m) | 2.18% | 1.31× |
| 2015-03-31 | $32.60M | (m) | $36.05M | $3.45M | (m) | $729.96M | (m) | $18.53M | (m) | (m) | 4.47% | 1.95× |
| 2014-12-31 | $19.26M | (m) | $61.00M | $41.74M | (m) | $717.57M | (m) | $1.38M | (m) | (m) | 2.68% | 44.33× |
| 2014-09-30 | $61.39M | (m) | $57.95M | $-3.43M | (m) | (m) | (m) | $7.84M | (m) | (m) | (m) | 7.40× |
| 2014-06-30 | $56.91M | (m) | $57.32M | $414.00K | (m) | (m) | (m) | $2.92M | (m) | (m) | (m) | 19.64× |
| 2014-03-31 | $40.26M | (m) | $46.34M | $6.09M | (m) | (m) | (m) | $460.00K | (m) | (m) | (m) | 100.74× |
| 2013-12-31 | $17.80M | (m) | $66.42M | $48.62M | (m) | $702.99M | (m) | $2.12M | (m) | (m) | 2.53% | 31.33× |
| 2013-09-30 | $-2.66M | (m) | $3.07M | $5.73M | (m) | $121.86M | (m) | $5.38M | (m) | (m) | -2.19% | 0.57× |
| 2013-06-30 | $44.00K | (m) | $4.14M | $4.09M | (m) | (m) | (m) | $10.90M | (m) | (m) | (m) | 0.38× |
| 2013-03-31 | $15.91M | (m) | $15.97M | $55.00K | (m) | (m) | (m) | $11.16M | (m) | (m) | (m) | 1.43× |
| 2012-12-31 | $30.82M | (m) | $75.27M | $44.45M | (m) | $85.04M | (m) | $64.52M | (m) | (m) | 36.24% | 1.17× |
| 2012-09-30 | $35.49M | (m) | $79.20M | $43.72M | (m) | (m) | (m) | $12.44M | (m) | (m) | (m) | 6.37× |
| 2012-06-30 | $32.43M | (m) | $75.59M | $43.15M | (m) | $660.42M | (m) | $7.42M | (m) | (m) | 4.91% | 10.19× |
| 2012-03-31 | $16.80M | (m) | $57.87M | $41.07M | (m) | $642.76M | (m) | $8.00M | (m) | (m) | 2.61% | 7.24× |
| 2011-12-31 | $14.92M | (m) | $57.64M | $42.72M | (m) | $619.80M | (m) | $7.23M | (m) | (m) | 2.41% | 7.97× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $26.59M | (m) | $66.88M | $40.29M | (m) | $551.82M | (m) | $-12.85M | (m) | (m) | 4.82% | -5.20× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $45.87M | (m) | $76.62M | $30.75M | (m) | $527.62M | (m) | $-2.27M | (m) | (m) | 8.69% | -33.80× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |